 |
conjugate of human transferrin and a mutant diphtheria toxin (CRM 107) |
|---|---|
| Trade Name | Transmid |
| Orphan Indication | Malignant tumors of the central nervous system |
| USA Market Approval | USA |
| USA Designation Date | 2001-12-03 00:00:00 |
| Sponsor | Xenova Biomedix Limited;957 Budkingham Avenue, Slough; |
